Chehrenama M

No ORCID on file · 1 paper in corpus

2022

Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials.

The journal of headache and pain ·doi:10.1186/s10194-022-01470-4

BackgroundErenumab, a fully human monoclonal antibody that targets the calcitonin gene-related peptide receptor, has demonstrated efficacy and safety in the prevention of episodic and chronic migraine. There exists an unmet need to establis…